Crossmark

Cirsilineol inhibits RANKL-induced osteoclast activity and ovariectomy-induced bone loss via NF-κb/ERK/p38 signaling pathways

Published Online: 2024-05-14

Authors

Wang, Cong

Zeng, Rong

Li, Yong

He, Rongxin https://orcid.org/0000-0002-5937-3878
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81572124)

National Natural Science Foundation of China (82101649)

National Natural Science Foundation of China (82102597)

Natural Science Foundation of Zhejiang Province (LQ21H060007)

Natural Science Foundation of Zhejiang Province (LY19H060006)
License Information

Text and Data Mining valid from 2024-05-14

Version of Record valid from 2024-05-14
More Information

Article History

Received: 8 January 2024

Accepted: 1 May 2024

First Online: 14 May 2024

Declarations

:

: This work has been approved for animal ethics by the Second Affiliated Hospital, School of Medicine, Zhejiang University.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current